Patient Name : Mr Ravi kumar

DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM

Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:57 PM
Referred By : Self Barcode No : HY384553
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

VH00ORC-PATH - Male
Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 14.6 g/dL 13.0 - 17.0
colorimetric
RBC Count 4.9 10^6/µl 4.5 - 5.5
Electrical impedance
PCV 46.2 % 40 - 50
Calculated
MCV 94.2 fl 83 - 101
Calculated
MCH 29.8 pg 27 - 32
Calculated
MCHC 31.6 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 14.9 % 11.6 - 14.0
Calculated
RDW-SD * 49.9 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 8.6 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 58 % 40-80
Lymphocytes 37 % 20-40
Monocytes 3 % 2-10
Eosinophils 2 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Calculated
Neutrophils. 4.99 10^3/µl 2-7
Lymphocytes. 3.18 10^3/µl 1-3
Monocytes. 0.26 10^3/µl 0.2 - 1.0
Eosinophils. 0.17 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 243 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 11.4 fL 9.3 - 12.1
Calculated
PCT * 0.3 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 1 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:57 PM
Referred By : Self Barcode No : HY384553
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
PDW * 14.6 fL 8.3 - 25.0
Calculated
P-LCR * 35.4 % 18 - 50
Calculated
P-LCC * 86 % 44 - 140
Calculated
Mentzer Index * 19.22 % -
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 2 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Apr 01, 2024, 12:16 AM
Referred By : Self Barcode No : HY384553
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 5 mm/hr 0 - 10

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

AGE MALE FEMALE

1 DAY 0-2 0-2
2 - 7 DAYS 0-4 0-4
8 - 14 DAYS 0-17 0-17
15 DAYS - 17 YEARS 0-20 0-20
18 - 50 YEARS 0-10 0-12
51- 60 YEARS 0-12 0-19
61 - 70 YEARS 0-14 0-20
71 - 100 YEARS 0-30 0-35

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 3 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Apr 01, 2024, 12:01 AM
Referred By : Self Barcode No : HY384553
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

HbA1C

Glycosylated Hemoglobin (HbA1c) 4.9 % < 5.7

HPLC
Estimated Average Glucose * 93.93 mg/dL Refer Table Below
Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %

Non diabetic adults >=18 years <5.7

At risk (Prediabetes) 5.7 - 6.4

Diagnosing Diabetes >= 6.5

Age > 19 years

Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c.
Converse is true for a diabetic previously under good control but now poorly controlled. 2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life
expectancy and no significant cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of
< 7.0 % may not be appropriate.
Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary
glucose determinations ADA criteria for correlation between HbA1c & Mean plasma
glucose levels.

HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)

6 126 12 298

8 183 14 355

10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 4 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:50 PM
Referred By : Self Barcode No : ZC193319
Sample Type : FLUORIDE F Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting (BSF)

Glucose Fasting 87.2 mg/dL 70 - 100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 5 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 0.7 mg/dL 0.2 - 1.2

Photometric
Bilirubin Direct * 0.3 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect * 0.4 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 29.1 U/L 5 - 34
IFCC without P5P
SGPT/ALT 38.0 U/L 0 to 55
IFCC without P5P
SGOT/SGPT Ratio * 0.77 - -
Alkaline Phosphatase 84 U/L 40 - 150
IFCC
Total Protein 8.2 g/dL 6.4 - 8.3
Biuret
Albumin 5.0 gm/dL 3.8 - 5.0
BCG
Globulin * 3.2 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.56 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 20.8 U/L 12 - 64
Photometric

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is
by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile
flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all
cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and
globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune system. Low
total protein may

Indicate:
1.Bleeding
2.Liver disorder
3.Malnutrition
4.Agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive
water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low
albumin levels may be

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 6 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Caused by:
1.A poor diet (malnutrition).
2.Kidney disease.
3.Liver disease. High albumin levels may be caused by: Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 7 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 17.8 mg/dL 19 - 44.1

Urease
Creatinine 1.3 mg/dL 0.72 - 1.25
Photometric
Bun * 8.32 mg/dL 8.9 - 20.6
Urease
Bun/Creatinine Ratio * 6.4
Urea / Creatinine Ratio * 13.69
Uric Acid 8.0 mg/dL 3.5 - 7.2
Uricase
Calcium Serum 10.8 mg/dL 8.4 - 10.2
Arsenazo III
Phosphorus 3.8 mg/dL 2.3 - 4.7
Photometric
Sodium 144.7 mmol/L 136 - 145
Potentiometric
Potassium 5.0 mmol/L 3.5 - 5.1
Potentiometric
Chloride 97.7 mmol/L 98 - 107
Potentiometric

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate
a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling
in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these
symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes (sodium,potassium,and
chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells and organs. There has to
be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress and treatment of these
diseases.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 8 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 225 mg/dL <200

Enzymatic - Cholesterol Oxidase
Triglycerides 203 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 46.9 mg/dL >40
Accelerator Selective Detergent
Non HDL Cholesterol * 178.1 mg/dL <130
Calculated
LDL Cholesterol * 137.5 mg/dL <100
Calculated
V.L.D.L Cholesterol * 40.6 mg/dL < 30
Calculated
Chol/HDL Ratio * 4.8 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.34 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 2.93 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 9 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 10 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 126 ng/dL 35 - 193

CMIA
TotalnThyroxine (T4) 7.66 µg/dL 4.87 - 11.2
CMIA
Thyroid Stimulating Hormone (Ultrasensitive) 3.72 µIU/mL 0.35 - 4.94
CMIA

Interpretation:
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are significantly
elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome, multiple alterations
in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI) without evidence of
preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding Globulin (TBG) concentrations remain relatively constant in healthy
individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter TBG levels and may
cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid
Normal High High
hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 11 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Mar 31, 2024, 11:51 PM
Referred By : Self Barcode No : ZC193320
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Prostate Specific Antigen (PSA) Total

Prostate Specific Antigen-Total (PSA-Total) 0.3 ng/mL <4.0

CMIA

Interpretation:
Age (years) Ranges

< 40 <1.4

40 - 49 <2.0

50 - 59 <3.1

60 - 69 <4.1

>=70 <4.4

Prostate Specific Antigen (PSA) is a single-chain glycoprotein normally found in the cytoplasm of the epithelial cells lining the acini and ducts of the prostate gland. PSA is detected in the serum of males with normal, benign hyperplastic
and malignant prostate tissue and in patients with prostatitis. PSA is not detected (or detected at very low levels) in the serum of males without prostate tissue (because of radical prostatectomy or cytoprostatectomy) or in the serum of
most females. The fact that PSA is unique to prostate tissue makes it a suitable marker for monitoring men with cancer of the prostate. PSA is also useful for determining possible recurrence after therapy when used in conjunction with
other diagnostic indices. PSA levels increase in men with cancer of the prostate. After radical prostatectomy PSA levels routinely fall to a very low level, which may not be seen in patients undergoing radiation therapy. Monitoring PSA
levels appears to be useful in detecting residual disease and early recurrence of tumor. Therefore, serial PSA levels can help determine the success of prostatectomy and the need for further treatment, such as radiation, endocrine of
chemotherapy and in the monitoring of the effectiveness of therapy.
PSA levels should not be interpreted as absolute evidence of presence or the absence of malignant disease. Before treatment, patients with confirmed prostate carcinoma frequently have levels of PSA within the range observed in healthy
individuals. Elevated levels of PSA can be observed in the patients with nonmalignant disease. Measurement of PSA should always be used in conjunction with other diagnostic procedures, including information from the patients and
clinical evaluation.
The concentration of total PSA in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 12 of 13
 Patient Name : Mr Ravi kumar
DOB/Age/Gender : 31 Y 2 M 29 D/Male Sample Collected : Mar 31, 2024, 08:08 AM
Patient ID / UHID : 7767460/RCL2800348 Report Date : Apr 01, 2024, 03:49 AM
Referred By : Self Barcode No : YA468875
Sample Type : Spot Urine Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 30 mL -
Colour * Pale yellow - Pale yellow
Transparency * Clear - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 6.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.010 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Urine Protein (Albumin) Positive(Trace) - Negative
Urine Ketones (Acetone) Negative - Negative
Blood Negative - Negative
Leucocyte esterase Negative - Negative
Bilirubin Urine Negative - Negative
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 2-4 /hpf 0-5
Epithelial Cells * 1-2 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria Absent - Absent
Protozoa * Absent - Absent

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Visit Noida, .

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., House No. 59, south opposite of Block-1, madhuban Apartment Kailashpuri,
Malahi Pakri, kankarbagh, Behind raymond showroom, Patna, Bihar - 800020. "

Page 13 of 13
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.